ENSC (Ensysce) Tingkat bathi miturut bathi reged

Simbol resmi perusahaan Ensysce Biosciences (ENSC)

The gross margin history of Ensysce Biosciences (ENSC) demonstrates current efficiency, where the parameter value equals 0.00. Risks are associated with stringent FDA oversight and capital shortages leading to share dilution. Business protection is based on unique MPAR patents that block competitor entry. Revenues rely on demand from insurance companies and patients with chronic pain within the safe opioid segment.

Tingkat bathi miturut bathi reged: Ensysce (ENSC) kanggo 04.07.2022 - 19.11.2026

Rincian metrik keuangan lan pasar Ensysce Biosciences (ENSC)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:ENSC ensysce.com
Produk dadi Ensysce

Ensysce Biosciences (ENSC) is developing the specialized TAAP system to combat the opioid crisis, leveraging regulatory grants and technological uniqueness. By analyzing the gross profit margin on GURU.Markets, an investor can identify the portion of revenue remaining after direct production costs. This indicator measures the business's internal margin of safety, allowing for an assessment of the company's real operational efficiency before accounting for administrative expenses.